Opko Health has agreed to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases.
Hovione has obtained a US patent for a cheap capsule-based dry powder inhaler that it claims is cheaper for manufacturers to produce and easier for patients to use.
Copley Scientific expects the new version of its flow rate control technology for dry powder inhaler (DPI) testing to be in demand among both generic drug firms and pharmaceutical innovators.
The licensing and potential purchase of the Taper Dry Powder Inhaler (DPI) technology from 3M complements Adamis’ portfolio and future formulation expansion, Adamis says.
Dry powder inhaler firms may soon be able to eliminate lactose from formulations if a new high dispersibility particle production platform is successful in trials.
Drug giant Pfizer has completed its purchase of UK-based drug
delivery company Meridica in a move that it says will bolster its
activities in allergy and respiratory medicine.
3M has teamed up with MicroDose Technologies to market a new
metered dose inhaler that should be cheap to produce and deliver a
broad range of compounds.
UK-based packaging company Rexam has provided further evidence of
its commitment to the pharmaceutical sector with the purchase of
Plastic Omnium Medical, a company specialising in plastic
components for medical devices.